pulse

BOK stays pat, won’t move to change direction, but wary of ... [Updated with comments from BOK governor] The Bank of Korea chose to stay pat in the first rate-setting meeting for 2021 Friday and maintained to keep monetary policy loose and accommodative of the f..

headline 이미지

COVID-19 Live Updates

17 Jan 12:30

신종 코로나 발생 현황
World	Infections 94,447,699	Deaths 2,020,527
S. Korea	Infections 71,820	Deaths 1,236	Inspected 155,639

Related articles

Samsung Galaxy S21 is more apt and powerful but cheaper South Korea’s Samsung Electronics Co. latest flagship phone Galaxy S21 series are cheaper, smarter and snappier, powered with the most advanced display, chip, and camera plus an optional digital pen t..

SK Hynix sets a Korean private issue record with $2.5 bn overseas debt sale SK Hynix Inc. raised $2.5 billion in multi-tranche U.S. dollar-denominated bond issues, a record debt financing by a Korean Inc.The Korean chipmaker on Wednesday issued $500 million in three-year bond..

KRX claims Korean stocks undervalued against other G-20 members South Korean stocks are deemed undervalued against peers of other G20 economies, the Korea Exchange said Thursday in the backdrop of concerns for overshooting and overheating in the Korean market. Ac..

Chong Kun Dang’s Covid-19 cure shows positive results in Phase 2 trial Chong Kun Dang (CKD) reported positive interim results from the clinical trials of its investigational Covid-19 therapy Napabeltan (nafamostat mesylate), raising hope for the availability of one more ..

Market Kurly projects to have achieved near $1 bn sales milestone last year South Korea’s fresh food early morning delivery pioneer Market Kurly is estimated to have raked more than 1 trillion won ($910 million) in sales last year, a milestone achieved in just five years in ..

Fuel stations evolve with fast addition of EV chargers in S Korea Electric vehicle chargers were added by 20,000 units, while gas stations were reduced by nearly 100 in South Korea last year to underscore fast changing fueling and mobility landscape. According to t..

Celltrion submits IND for Phase 3 study of Prolia biosimilar in US South Korea’s Celltrion has submitted an investigational new drug application to the U.S. Food and Drug Administration (FDA) to conduct Phase 3 clinical trials for its biosimilar of Amgen’s osteoporos..

利앷텒�쒗솴 �뺣낫
KOSPI	3,085.90	64.03	-2.03%
KOSDAQ	964.44	15.85	-1.62%
Dollar/Won	1,099.50	3.50	0.32%

利앷텒�쒗솴 �뺣낫
1��	SamsungElec	88,000	-1.90%
2��	SK hynix	127,500	-2.30%
3��	LGCHEM	979,000	-3.07%
4��	SamsungElec(1P)	77,600	-1.52%
5��	SAMSUNG BIOLOGICS	804,000	-1.47%

利앷텒�쒗솴 �뺣낫
1��	Celltrion Healthcare	143,400	-8.02%
2��	Celltrionph	187,400	-9.51%
3��	HLB	91,700	-2.34%
4��	SEEGENE	179,900	-4.26%
5��	Alteogen	150,700	-1.12%

Updated : 15 Jan 3:59pm

Photos

MOST READ MOST RECENT

Biz

· Market Kurly projects to have achieved near $1 bn sales milestone last year
· Fuel stations evolve with fast addition of EV chargers in S Korea

Bio&Tech

· Celltrion submits IND for Phase 3 study of Prolia biosimilar in US
· Chong Kun Dang’s Covid-19 cure shows positive results in Phase 2 trial

Market

· SK Innovation bumps up debt offering upon 7-times oversubscription
· KRX claims Korean stocks undervalued against other G-20 members

Economy

· BOK stays pat, won’t move to change direction, but wary of over-speed in Kospi
· Private loans surge by record $189 billion in South Korea last year

Seoul

· S. Koreans advised against overseas travel until Feb 15
· ESG disclosure to be mandatory in phases for Kospi-listed firms

Asia

· Indonesia Extends 14-Day Entry Ban on Foreign Arrivals
· Labour sector reaches significant results in five years